Skip to main content
UniHealth

Doctor search

Nina C Botto, MD

Dermatology · San Francisco

NPI 1528299716

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
12
2 carriers
Offices
5
Since medical school
17 years
Graduated 2009

Offices

5 locations · UCSF Medical Group Business Services · University of California San Francisco

Looking this up.

Hospitals listed: UCSF Medical Center. That is not proof they admit you there this week.

Plans that list them

12 plans · 2 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Botto’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

12 of 12 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Imperial Courage Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Dynamic Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Senior Value (HMO C-SNP)Imperial Health Plan of California, Inc.ListedSep 1, 2026

State licence records

1 licence

  • Illinois 125056327Temporary Medical Permit · since 2009 · expires 2010-06-23Specialty on the licence: Internal Medicine
    ExpiredNo board action on this licenceCheck it with the state

We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend it
    Overall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for UCSF Medical Center

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at UCSF Medical Center
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths4.9 (3.79 to 6.02) · 7,590 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits12.8 (11.3 to 14.4) · 2,019 casesWorseJan 2024 – Dec 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths139.4 (110.22 to 168.58) · 452 casesBetterJul 2022 – Jun 2024
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.622BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.626BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0.491BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.8 (0.7 to 1) · 2,336 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.24 (0.58 to 1.9) · 4,689 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.05 (0.89 to 1.2)No differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.9 · 89 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.5 · 85 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10.1 · 132 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.6 · 454 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 618 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.6 · 380 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.7 · 5,000 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.22 (0.06 to 0.38) · 15,965 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.2 (0.05 to 0.35) · 17,859 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.85 (0 to 1.83) · 4,184 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2 (1.1 to 2.9) · 6,516 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths7.35 (4.49 to 10.21) · 3,989 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5 (3.22 to 6.77) · 4,087 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.95 (0.74 to 3.15) · 2,034 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.95 (0.63 to 1.28) · 15,431 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 399 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.899No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.689No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.224No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16 · 156 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20 · 564 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits60.3 · 160 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-9.7 · 550 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits44.1 · 660 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.8 · 667 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.7 (4.8 to 6.7) · 2,019 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6 · 421 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.5 · 53 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20 · 107 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.9 (11.3 to 17.1) · 3,247 casesNo differentJan 2022 – Dec 2024

What patients said (3,181 patients answered, 25% of those asked)

Patient survey stars by topic at UCSF Medical Center
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at UCSF Medical Center
Room was "always" clean71%
Nurses "always" communicated well80%
Doctors "always" communicated well80%
Staff "always" explained61%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge87%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)76%
Staff "always" explained new medications75%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully78%
Nurses "always" treated them with courtesy and respect86%
"Always" quiet at night50%
"YES", patients would definitely recommend the hospital81%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$44,868

Medicare paid this office $44,868 for 316 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Short return visit (20+ min)167$12,780$54
Return visit (30+ min)108$11,578$77
Destruction of precancer skin growth, 1 growth98$6,620$48
Destruction of skin growth, 1-14 growths33$2,543$64
Short return visit50$2,036$31
See all 12 services
Every Original Medicare service billed
Short return visit (20+ min)167$12,780$54
Return visit (30+ min)108$11,578$77
Destruction of precancer skin growth, 1 growth98$6,620$48
Destruction of skin growth, 1-14 growths33$2,543$64
Short return visit50$2,036$31
New patient visit (30+ min)26$1,743$67
Destruction of precancer skin growth, 15 or more growths12$1,658$75
Biopsy of related skin growth, first growth54$1,563$26
New patient visit (45+ min)13$1,347$104
Destruction of precancer skin growth, 2-14 growths80$873$2
New patient visit (15+ min)11$401$36
Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes12$137$11

Procedures Medicare counted

Procedure volume Medicare published
Removal of skin lesions323More than 83% of doctors who do this
Skin biopsy79More than 73% of doctors who do this

Procedures year by year

Procedures billed to Original Medicare by year
Procedure201920202021202220232024
Destruction of precancer skin growth, 2-14 growths240314426515484487
Destruction of precancer skin growth, 1 growth88103112134137137
Biopsy of related skin growth, first growth515159306160
Destruction of skin growth, 1-14 growths322432302940
Destruction of precancer skin growth, 15 or more growths––23221822
Biopsy of related skin growth, each additional growth201322–20–

Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.

Who their Medicare patients are

316 Original Medicare patients in 2024. Average age 74 · Under 65 5% · 85 and older 10% · Women 67% · Also on Medicaid 19% · Health risk score 0.93. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.

Conditions among them: High blood pressure 54% · Cancer 16% · Depression 16% · Coronary heart disease 13% · Chronic kidney disease 13% · Atrial fibrillation 13% · Diabetes 12% · COPD 7% · Stroke 7% · Heart failure 5% · Dementia 4%.

The office billed $425,037, Medicare allowed $61,773 and paid $44,868; for 1,302 services of 23 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20243161,302740.93$425,037$44,868
20232981,269740.98$426,929$44,505
20222921,236751.03$393,120$41,201
20212771,119741.06$364,493$36,746
2020212860721.09$254,748$22,109
2019217788721.15$250,590$21,947
2018272717731.21$233,962$22,974
2017282956741.31$269,802$26,915
20163261,105731.23$328,752$32,388
2015254841731.29$244,972$23,632
2014324992701.27$305,908$31,606
2013110301721.17$87,353$9,647

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 11 services

Original Medicare services billed in 2023
Return visit (30+ min)130$13,552$81
Short return visit (20+ min)157$10,734$53
Destruction of precancer skin growth, 1 growth99$6,286$46
New patient visit (45+ min)24$2,624$109
Destruction of skin growth, 1-14 growths22$1,757$61
Destruction of precancer skin growth, 15 or more growths13$1,611$90
New patient visit (30+ min)22$1,546$70
Biopsy of related skin growth, first growth56$1,342$22
Short return visit40$1,159$26
Destruction of precancer skin growth, 2-14 growths82$817$2
Biopsy of related skin growth, each additional growth16$354$18

2022: 11 services

Original Medicare services billed in 2022
Return visit (30+ min)132$13,864$80
Short return visit (20+ min)134$8,711$50
Destruction of precancer skin growth, 1 growth100$5,854$44
New patient visit (45+ min)25$2,385$95
New patient visit (30+ min)25$1,763$71
Destruction of precancer skin growth, 15 or more growths18$1,710$78
Destruction of skin growth, 1-14 growths27$1,634$54
Short return visit32$1,059$26
Destruction of precancer skin growth, 2-14 growths82$839$2
Biopsy of related skin growth, first growth29$760$25
New patient visit (15+ min)13$433$33

2021: 13 services

Original Medicare services billed in 2021
Short return visit (20+ min)145$10,130$54
Return visit (30+ min)63$6,676$88
Destruction of precancer skin growth, 1 growth85$5,034$45
New patient visit (30+ min)44$2,714$62
New patient visit (45+ min)18$1,957$109
Destruction of precancer skin growth, 15 or more growths19$1,683$73
Destruction of skin growth, 1-14 growths32$1,567$49
Biopsy of related skin growth, first growth57$1,313$22
Short return visit36$1,038$25
Destruction of precancer skin growth, 2-14 growths73$782$2
New patient visit (15+ min)18$659$37
Biopsy of related skin growth, each additional growth17$402$18
Punch biopsy, first skin growth11$269$24

2020: 10 services

Original Medicare services billed in 2020
Short return visit (20+ min)124$6,418$41
Destruction of precancer skin growth, 1 growth80$4,274$41
Short return visit64$1,531$20
Destruction of skin growth, 1-14 growths21$1,521$63
Return visit (30+ min)18$1,167$61
Biopsy of related skin growth, first growth44$1,150$23
New patient visit (15+ min)32$1,138$36
New patient visit (30+ min)13$887$68
Destruction of precancer skin growth, 2-14 growths55$499$2
Biopsy of related skin growth, each additional growth13$229$18

2019: 9 services

Original Medicare services billed in 2019
Short return visit (20+ min)127$6,619$39
Destruction of precancer skin growth, 1 growth67$3,683$42
Return visit (30+ min)34$2,214$62
Destruction of skin growth, 1-14 growths27$2,116$66
Short return visit86$1,922$21
Biopsy of related skin growth, first growth43$1,119$22
New patient visit (15+ min)21$776$37
Destruction of precancer skin growth, 2-14 growths47$472$2
Biopsy of related skin growth, each additional growth12$358$18

2018: 10 services

Original Medicare services billed in 2018
Short return visit (20+ min)150$7,876$43
Destruction of precancer skin growth, 1 growth57$2,955$44
Return visit (30+ min)30$2,170$68
New patient visit (15+ min)49$2,046$42
Biopsy of single growth of skin and/or tissue50$1,715$34
Destruction of skin growth, 1-14 growths25$1,704$63
Short return visit67$1,594$22
New patient visit (30+ min)21$1,110$53
Biopsy of each additional growth of skin and/or tissue13$371$22
Destruction of precancer skin growth, 2-14 growths40$347$2

2017: 10 services

Original Medicare services billed in 2017
Short return visit (20+ min)146$8,170$41
Destruction of precancer skin growth, 1 growth74$3,982$43
Return visit (30+ min)36$2,364$66
Short return visit91$2,314$21
Biopsy of single growth of skin and/or tissue60$2,238$32
New patient visit (15+ min)48$1,899$40
Destruction of skin growth, 1-14 growths26$1,796$60
New patient visit (30+ min)12$746$62
Destruction of precancer skin growth, 2-14 growths55$569$2
Biopsy of each additional growth of skin and/or tissue17$568$23

2016: 11 services

Original Medicare services billed in 2016
Short return visit (20+ min)168$8,763$40
Destruction of precancer skin growth, 1 growth71$4,120$42
Short return visit122$2,866$20
Biopsy of single growth of skin and/or tissue74$2,687$32
Return visit (30+ min)37$2,678$65
New patient visit (15+ min)63$2,415$38
Destruction of skin growth, 1-14 growths38$2,394$58
New patient visit (30+ min)28$1,676$60
Long return visit (40+ min)17$1,596$94
Biopsy of each additional growth of skin and/or tissue31$948$23
Destruction of precancer skin growth, 2-14 growths57$563$2

2015: 11 services

Original Medicare services billed in 2015
Short return visit (20+ min)110$5,188$40
Destruction of precancer skin growth, 1 growth53$2,724$42
Return visit (30+ min)31$2,186$68
Biopsy of single growth of skin and/or tissue66$2,094$31
Short return visit75$1,751$20
Destruction of skin growth, 1-14 growths24$1,676$60
New patient visit (30+ min)25$1,574$63
New patient visit (15+ min)37$1,309$35
Biopsy of each additional growth of skin and/or tissue22$705$21
Short return visit (20+ min)11$459$42
Destruction of precancer skin growth, 2-14 growths47$415$2

2014: 11 services

Original Medicare services billed in 2014
Short return visit (20+ min)135$8,158$42
Destruction of precancer skin growth, 1 growth63$3,570$44
New patient visit (15+ min)81$3,201$40
Biopsy of single growth of skin and/or tissue79$3,152$35
New patient visit (30+ min)52$3,052$59
Destruction of skin growth, 1-14 growths34$2,289$60
Long return visit (40+ min)15$1,989$95
Short return visit74$1,858$21
Return visit (30+ min)21$1,453$63
Biopsy of each additional growth of skin and/or tissue23$648$20
Destruction of precancer skin growth, 2-14 growths49$473$2

2013: 8 services

Original Medicare services billed in 2013
Short return visit (20+ min)49$2,292$41
New patient visit (30+ min)25$1,577$63
Destruction of precancer skin growth, 1 growth25$1,363$50
Biopsy of single growth of skin and/or tissue25$931$37
Destruction of skin growth, 1-14 growths13$852$66
New patient visit (15+ min)20$829$41
Destruction of precancer skin growth, 2-14 growths20$372$4
Short return visit16$327$20

Medicaid work

$5,656 in 2024

Medicaid paid $5,656 for 55 billed services this clinician did in 2024, up to 14 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Short return visit (20+ min)41$3,792
Return visit (30+ min)14$1,864
Medicaid work by year
202455214$5,656
202336118$3,544
202256116$5,358
202144215$2,879
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Return visit (30+ min)36$3,544

2022

Largest Medicaid services in 2022
Return visit (30+ min)56$5,358

2021

Largest Medicaid services in 2021
Return visit (30+ min)28$2,312
Short return visit (20+ min)16$567

Drugs they prescribed that Part D paid

$290,173

Pharmacies billed $290,173 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 868) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.

778 generic and 90 brand-name prescriptions · $290,173 in drug cost · 27 antibiotic prescriptions to 13 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Dupixent35$131,852$3,767
Dupixent15$114,236$7,616
Tacrolimus65$7,336$113
Clobetasol Propionate85$3,856$45
Desonide52$1,904$37
See all 22 drugs
Every Part D drug this clinician prescribed
Dupixent35$131,852$3,767
Dupixent15$114,236$7,616
Tacrolimus65$7,336$113
Clobetasol Propionate85$3,856$45
Desonide52$1,904$37
Valacyclovir29$1,470$51
Ketoconazole51$1,193$23
Ciclopirox32$1,180$37
Betamethasone Dipropionate20$1,168$58
Econazole Nitrate25$1,112$44
Metronidazole22$1,054$48
Fluocinonide29$897$31
Desoximetasone23$840$37
Doxycycline Hyclate25$826$33
Triamcinolone Acetonide67$769$11
Gabapentin40$681$17
Minoxidil56$551$10
Fluocinolone Acetonide11$388$35
Mupirocin29$179$6
Mometasone Furoate11$104$9
Prednisone14$57$4
Hydrocortisone17$36$2

Year by year

Part D prescribing by year
20248682080% (0)10%$290,173
20237852190% (0)None$187,337
20226842050% (0)9%$223,523
20216041670% (0)10%$153,936
20204241340% (0)13%$115,400
20194331490% (0)8%$33,303
20183931540% (0)9%$28,146
20174941680% (0)11%$55,362
20165021670% (0)13%$47,845
20153571470% (0)12%$42,929
20145111730% (0)None$39,773
201315677NoneNone$11,457

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 22 drugs

Part D drugs prescribed in 2023
Dupixent30$130,563$4,352
Clobetasol Propionate95$9,167$96
Tacrolimus36$3,859$107
Econazole Nitrate17$1,739$102
Gabapentin84$1,720$20
Desonide30$1,639$55
Betamethasone Dipropionate18$1,556$86
Valacyclovir25$1,436$57
Metronidazole19$1,391$73
Triamcinolone Acetonide63$1,140$18
Ciclopirox27$1,104$41
Fluocinonide22$1,058$48
Ketoconazole37$1,036$28
Doxycycline Hyclate21$660$31
Mupirocin28$498$18
Clindamycin Phosphate13$455$35
Desoximetasone14$447$32
Minoxidil38$429$11
Methotrexate16$256$16
Nystatin13$256$20
Montelukast13$246$19
Hydrocortisone14$79$6

2022: 18 drugs

Part D drugs prescribed in 2022
Dupixent27$94,904$3,515
Acitretin14$8,238$588
Clobetasol Propionate77$8,174$106
Fluorouracil14$6,922$494
Tacrolimus27$4,683$173
Metronidazole19$2,353$124
Desonide23$1,703$74
Fluocinonide32$1,546$48
Doxycycline Hyclate37$1,446$39
Gabapentin77$1,398$18
Triamcinolone Acetonide66$1,169$18
Ketoconazole32$877$27
Valacyclovir13$709$55
Desoximetasone16$601$38
Econazole Nitrate18$432$24
Mupirocin19$161$8
Prednisone11$86$8
Hydrocortisone12$55$5

2021: 16 drugs

Part D drugs prescribed in 2021
Dupixent31$100,489$3,242
Clobetasol Propionate85$5,136$60
Tacrolimus13$2,899$223
Metronidazole23$2,373$103
Fluocinonide36$2,047$57
Calcipotriene11$1,901$173
Desonide26$1,284$49
Doxycycline Hyclate25$1,243$50
Triamcinolone Acetonide51$991$19
Valacyclovir19$864$45
Ketoconazole25$863$35
Gabapentin49$704$14
Desoximetasone12$650$54
Nystatin20$350$17
Mupirocin22$221$10
Hydrocortisone25$132$5

2020: 13 drugs

Part D drugs prescribed in 2020
Dupixent31$91,788$2,961
Tacrolimus22$7,194$327
Metronidazole14$1,615$115
Clobetasol Propionate32$1,548$48
Doxycycline Hyclate30$1,292$43
Valacyclovir22$1,148$52
Triamcinolone Acetonide61$988$16
Ketoconazole28$923$33
Fluocinonide17$911$54
Gabapentin21$362$17
Mupirocin19$187$10
Prednisone12$180$15
Hydrocortisone17$84$5

2019: 12 drugs

Part D drugs prescribed in 2019
Metronidazole16$3,854$241
Clobetasol Propionate31$2,517$81
Hydroxychloroquine Sulfate15$1,778$119
Desoximetasone15$1,293$86
Valacyclovir23$1,161$50
Fluocinonide16$1,018$64
Ketoconazole36$883$25
Triamcinolone Acetonide53$820$15
Mupirocin30$341$11
Nystatin14$246$18
Gabapentin17$245$14
Hydrocortisone26$174$7

2018: 11 drugs

Part D drugs prescribed in 2018
Clobetasol Propionate31$3,753$121
Tacrolimus11$3,072$279
Ketoconazole45$1,525$34
Fluocinonide19$1,369$72
Econazole Nitrate11$1,345$122
Triamcinolone Acetonide55$795$14
Doxycycline Hyclate11$468$43
Gabapentin22$337$15
Valacyclovir16$311$19
Hydrocortisone34$241$7
Mupirocin17$156$9

2017: 11 drugs

Part D drugs prescribed in 2017
Clobetasol Propionate58$12,095$209
Fluocinonide36$2,744$76
Metronidazole13$2,507$193
Econazole Nitrate13$2,462$189
Ketoconazole51$2,187$43
Triamcinolone Acetonide61$815$13
Doxycycline Hyclate16$613$38
Hydrocortisone52$326$6
Mupirocin27$257$10
Nystatin12$197$16
Gabapentin19$190$10

2016: 10 drugs

Part D drugs prescribed in 2016
Clobetasol Propionate70$19,097$273
Desonide20$4,058$203
Metronidazole18$3,194$177
Fluocinonide25$2,071$83
Triamcinolone Acetonide73$1,678$23
Ketoconazole54$1,628$30
Doxycycline Hyclate17$1,300$76
Hydrocortisone50$393$8
Mupirocin14$212$15
Gabapentin14$109$8

2015: 10 drugs

Part D drugs prescribed in 2015
Clobetasol Propionate46$15,908$346
Desonide24$4,511$188
Metronidazole19$2,666$140
Fluocinonide32$2,377$74
Triamcinolone Acetonide58$1,463$25
Doxycycline Hyclate15$1,399$93
Ketoconazole21$561$27
Mupirocin15$120$8
Hydrocortisone14$114$8
Prednisone11$53$5

2014: 12 drugs

Part D drugs prescribed in 2014
Desonide56$8,419$150
Clobetasol Propionate69$5,242$76
Metronidazole23$2,935$128
Triamcinolone Acetonide83$2,131$26
Fluocinonide26$1,796$69
Doxycycline Hyclate12$1,443$120
Clindamycin Phosphate16$1,140$71
Econazole Nitrate18$969$54
Ketoconazole31$788$25
Mupirocin22$301$14
Gabapentin24$194$8
Hydrocortisone14$84$6

2013: 3 drugs

Part D drugs prescribed in 2013
Desonide12$1,517$126
Triamcinolone Acetonide40$804$20
Clobetasol Propionate21$709$34

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
74.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1528299716
Licence
IL 125056327Illinois 125056327: Expired
Group
UCSF Medical Group Business Services · University of California San Francisco
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
Yes
Taxonomy
Internal medicine (207R00000X)
Mailing address
2650 Ridge Ave, Evanston, IL, 60201
NPI first listed
2009-08-05
NPI last updated
2009-08-05

This is when the NPI record was last certified, not a medical board exam.